Single-Nucleotide Polymorphism Array-Based Karyotyping of Acute Promyelocytic Leukemia
Author(s) -
Inés GómezSeguí,
Dolors Sánchez-Izquierdo,
Eva Barragán,
Esperanza Such,
Irene Luna,
Maria LópezPavía,
Mariam Ibáñez,
Eva Villamón,
Carmen Alonso,
Iván Martín,
Marta Llop,
Sandra Dolz,
Óscar Fuster,
Pau Montesinos,
Carolina Cañigral,
Blanca Boluda,
Claudia Salazar,
José Cervera,
Miguel Á. Sanz
Publication year - 2014
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0100245
Subject(s) - snp array , breakpoint , acute promyelocytic leukemia , gene duplication , chromosomal translocation , biology , dup , karyotype , leukemia , cytogenetics , snp , npm1 , phenotype , single nucleotide polymorphism , genetics , microbiology and biotechnology , chromosome , genotype , gene , retinoic acid
Acute promyelocytic leukemia (APL) is characterized by the t(15;17)(q22;q21), but additional chromosomal abnormalities (ACA) and other rearrangements can contribute in the development of the whole leukemic phenotype. We hypothesized that some ACA not detected by conventional techniques may be informative of the onset of APL. We performed the high-resolution SNP array (SNP-A) 6.0 (Affymetrix) in 48 patients diagnosed with APL on matched diagnosis and remission sample. Forty-six abnormalities were found as an acquired event in 23 patients (48%): 22 duplications, 23 deletions and 1 Copy-Neutral Loss of Heterozygocity (CN-LOH), being a duplication of 8(q24) (23%) and a deletion of 7(q33-qter) (6%) the most frequent copy-number abnormalities (CNA). Four patients (8%) showed CNAs adjacent to the breakpoints of the translocation. We compared our results with other APL series and found that, except for dup(8q24) and del(7q33-qter), ACA were infrequent (≤3%) but most of them recurrent (70%). Interestingly, having CNA or FLT3 mutation were mutually exclusive events. Neither the number of CNA, nor any specific CNA was associated significantly with prognosis. This study has delineated recurrent abnormalities in addition to t(15;17) that may act as secondary events and could explain leukemogenesis in up to 40% of APL cases with no ACA by conventional cytogenetics.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom